Atai Life Sciences Other Operating Income or Expenses 2020-2024 | ATAI
Atai Life Sciences other operating income or expenses from 2020 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
| Atai Life Sciences Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| Atai Life Sciences Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.208B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.379B | 12.93 |
| Quest Diagnostics (DGX) | United States | $17.308B | 17.75 |
| DaVita (DVA) | United States | $13.689B | 16.84 |
| Encompass Health (EHC) | United States | $9.303B | 22.88 |
| Chemed (CHE) | United States | $8.694B | 26.73 |
| Elanco Animal Health (ELAN) | United States | $7.242B | 16.28 |
| Option Care Health (OPCH) | United States | $5.321B | 26.14 |
| RadNet (RDNT) | United States | $4.963B | 117.74 |
| Amedisys (AMED) | United States | $3.181B | 22.75 |
| Astrana Health (ASTH) | United States | $2.805B | 39.69 |
| LifeStance Health (LFST) | United States | $2.579B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.399B | 29.12 |
| U.S Physical Therapy (USPH) | United States | $1.274B | 34.50 |
| Pennant (PNTG) | United States | $1.057B | 50.71 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.022B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |